Equillium, Inc. (EQ)
NASDAQ: EQ · Real-Time Price · USD
1.400
+0.100 (7.69%)
At close: Jan 28, 2026, 4:00 PM EST
1.390
-0.010 (-0.72%)
After-hours: Jan 28, 2026, 7:34 PM EST
Equillium Market Cap
Equillium has a market cap or net worth of $85.25 million as of January 28, 2026. Its market cap has increased by 243.44% in one year.
Market Cap
85.25M
Enterprise Value
46.79M
1-Year Change
243.44%
Ranking
Category
Stock Price
$1.40
Market Cap Chart
Since October 12, 2018, Equillium's market cap has decreased from $234.54M to $85.25M, a decrease of -63.65%. That is a compound annual growth rate of -12.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 27, 2026 | 79.16M | -16.13% |
| Dec 31, 2025 | 94.38M | 256.04% |
| Dec 31, 2024 | 26.51M | 4.40% |
| Dec 29, 2023 | 25.39M | -30.27% |
| Dec 30, 2022 | 36.41M | -67.14% |
| Dec 31, 2021 | 110.80M | -16.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 12, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ALX Oncology Holdings | 80.24M |
| Pliant Therapeutics | 79.27M |
| Coeptis Therapeutics Holdings | 79.12M |
| Annovis Bio | 78.45M |
| Mereo BioPharma Group | 78.31M |
| ImageneBio | 75.83M |
| PolyPid | 75.69M |
| Pelthos Therapeutics | 75.69M |